Switch to:

Key Ratios

New Key Statistics Module, Z-Score and F-Score
Market Cap $M1,655Revenue (TTM) $M5.4Net Margin (%)-4,930.2Altman Z-Score6.3
Enterprise Value $M1,353EPS (TTM) $-5.5Operating Margin %-4,920.3Piotroski F-Score4
P/E(ttm)--Beneish M-Score-0.3Pre-tax Margin (%)-4,930.2Higher ROA y-yN
Price/Book4.910-y EBITDA Growth Rate %6.6Quick Ratio4.8Cash flow > EarningsY
Price/Sales2725-y EBITDA Growth Rate %35.4Current Ratio5.0Lower Leverage y-yY
Price/Free Cash Flow--y-y EBITDA Growth Rate %--ROA % (ttm)-83.4Higher Current Ratio y-yY
Dividend Yield %--PEG--ROE % (ttm)-111.7Less Shares Outstanding y-yN
Payout Ratio %--Shares Outstanding M54.8ROIC % (ttm)-969.4Gross Margin Increase y-yN

Gurus Latest Trades with SRPT

Number of guru portfolios checked: 69.
Ticker Guru Date Action
Impact Price Range
Current Price Change from Average Comment Current Shares

SRPT is held by these investors:

SRPT: Insider Buys/Sells

Click Here for All Insider Trades.
InsiderPosition Date Trades Shares Trade Price ($) Change (%) Details
Mahatme SandeshSenior Vice President, CFO 2016-10-17Sell30,000$50.08-41.09view
Kaye Edward M. MDPresident, CEO & CMO 2016-09-22Sell40,179$60-50.83view
Howton David TSVP, General Counsel 2016-09-22Sell7,000$60-50.83view
Ruff ShamimSVP, Regulatory Affairs & Qual 2016-09-22Sell7,311$60-50.83view
Aphale JayantVP, Technical Operations 2016-09-19Sell35,000$50-41view
Kaye Edward M. MDPresident, CEO & CMO 2016-09-19Sell24,352$50-41view
Howton David TSVP, General Counsel 2016-09-19Sell9,304$50-41view
Kaye Edward M. MDSVP Interim CEO & CMO 2016-09-14Sell24,557$30-1.67view
BEHRENS M KATHLEENDirector 2016-03-16Buy75,000$16.2881.2view
Barry RichardDirector 2016-03-14Buy75,000$15.6688.38view

Press Releases about SRPT :

Quarterly/Annual Reports about SRPT:

News about SRPT:

Articles On GuruFocus.com
Steven Cohen Sells Alphabet, Apple, Amazon Mar 07 2017 
Sarepta Shares Tumble Following FDA Committee's Decision Apr 26 2016 
Sarepta Therapeutics Inc (SRPT) Will File NDA; Analysts Have Mixed Ratings May 20 2015 
Wednesday’s Pre-Market Insights: Yahoo! Inc. (YHOO), Sarepta Therapeutics Inc (SRPT), Time Warner May 20 2015 
Steven Cohen Keeps on Buying Biotechnological Companies May 04 2015 
Ebola: Is The Cure Out There? Oct 14 2014 
Insiders Are Buying Fate Therapeutics Oct 09 2013 

More From Other Websites
Today's Research Reports on Biotech Stocks to Watch: Amicus Therapeutics and Sarepta Therapeutics Mar 17 2017
Sarepta Therapeutics Announces Presentations at the 2017 MDA Scientific Conference Mar 17 2017
Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bearish Manner : SRPT-US : March... Mar 17 2017
PTC Therapeutics Buys Duchenne Drug for $140M Mar 16 2017
Sarepta's DMD Drug Launch Slow; What's in Store for 2017? Mar 13 2017
Trump nominates FDA head with deep ties to drug companies Mar 10 2017
Payor Re-Evaluation On Exondys Positive For Sarepta Mar 10 2017
Adam Feuerstein Weighs In On Novo-GBT Rumors, Undue Sarepta Volatility, Unprofitable Business Of... Mar 10 2017
Vetr Advises Hold On Sarepta Mar 07 2017
SAREPTA THERAPEUTICS, INC. Financials Mar 04 2017
Market Action Is Boring but Necessary Mar 03 2017
Biotech's Outlook Strengthens After President Trump's Speech: Today's Reports on Sarepta... Mar 03 2017
Sarepta Therapeutics, Inc. breached its 50 day moving average in a Bullish Manner : SRPT-US : March... Mar 03 2017
Sarepta Therapeutics to Present Company Overview at the Cowen and Company 37th Annual Health Care... Mar 02 2017
Sarepta Therapeutics: What Goes Down Must Go Up Mar 02 2017
Sarepta Therapeutics, Inc. :SRPT-US: Earnings Analysis: Q4, 2016 By the Numbers : March 2, 2017 Mar 02 2017
Morning Movers: Shake Shack Sinks, Abercrombie & Fitch Jumps, Valeant Climbs Mar 02 2017
Coverage initiated on Sarepta Therapeutics by Instinet Mar 02 2017

Add Notes, Comments

If you want to ask a question or report a bug, please create a support ticket.
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)